Literature DB >> 16962650

Effects of osemozotan, ritanserin and azasetron on cocaine-induced behavioral sensitization in mice.

Yukio Ago1, Shigeo Nakamura, Aiko Hayashi, Soichi Itoh, Akemichi Baba, Toshio Matsuda.   

Abstract

Repeated intermittent administration of psychostimulants causes behavioral sensitization in rodents. Previous studies using serotonin (5-HT) receptor ligands show that the 5-HT system is involved in cocaine-induced behavioral sensitization in rats, but the role of the 5-HT system has not been studied in mice. The present study examined the effects of the 5-HT(1A) receptor agonist osemozotan, the 5-HT(2) receptor antagonist ritanserin and the 5-HT(3) receptor antagonist azasetron on cocaine-induced behavioral sensitization in male ddY mice. Repeated administration of cocaine for 7 days enhanced cocaine-induced locomotor activity, and this sensitization was observed even after withdrawal for 7-14 days. Cocaine-induced behavioral sensitization after a 7-day withdrawal was significantly reduced with the coadministration of osemozotan, ritanserin or azasetron with cocaine repeatedly for 7 days. A single injection of osemozotan or ritanserin before cocaine challenge also reduced repeated cocaine-induced behavioral sensitization. However, none of these ligands inhibited cocaine-induced behavioral sensitization, when each drug was administered for 7 days after repeated cocaine administration. These results suggest that the central 5-HT system plays a role in the development and expression, but not maintenance, of behavioral sensitization in cocaine-treated mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962650     DOI: 10.1016/j.pbb.2006.07.036

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  7 in total

1.  One-trial behavioral sensitization in preweanling rats: differential effects of cocaine, methamphetamine, methylphenidate, and D-amphetamine.

Authors:  Sanders A McDougall; Olga O Kozanian; Venuz Y Greenfield; Leslie R Horn; Arnold Gutierrez; Alena Mohd-Yusof; Kevin A Castellanos
Journal:  Psychopharmacology (Berl)       Date:  2011-05-03       Impact factor: 4.530

2.  Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.

Authors:  Alena Mohd-Yusof; Ana Veliz; Krista N Rudberg; Michelle J Stone; Ashley E Gonzalez; Sanders A McDougall
Journal:  Psychopharmacology (Berl)       Date:  2015-12-09       Impact factor: 4.530

3.  5-HT1A Autoreceptors in the Dorsal Raphe Nucleus Convey Vulnerability to Compulsive Cocaine Seeking.

Authors:  In-Jee You; Sherie R Wright; Alvaro L Garcia-Garcia; Andrew R Tapper; Paul D Gardner; George F Koob; E David Leonardo; Laura M Bohn; Sunmee Wee
Journal:  Neuropsychopharmacology       Date:  2015-09-01       Impact factor: 7.853

4.  Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.

Authors:  Sanders A McDougall; Krista N Rudberg; Ana Veliz; Janhavi M Dhargalkar; Aleesha S Garcia; Loveth C Romero; Ashley E Gonzalez; Alena Mohd-Yusof; Cynthia A Crawford
Journal:  Behav Brain Res       Date:  2017-03-08       Impact factor: 3.332

Review 5.  The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.

Authors:  E A Engleman; Z A Rodd; R L Bell; J M Murphy
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

6.  Early ontogeny of D-amphetamine-induced one-trial behavioral sensitization.

Authors:  Sanders A McDougall; Charlotte M Nuqui; Anthony T Quiroz; Carrissa M Martinez
Journal:  Pharmacol Biochem Behav       Date:  2013-01-27       Impact factor: 3.533

7.  Role of Prefrontal Serotonergic and Dopaminergic Systems in Encounter-Induced Hyperactivity in Methamphetamine-Sensitized Mice.

Authors:  Tatsunori Tanaka; Yukio Ago; Chiaki Umehara; Emina Imoto; Shigeru Hasebe; Hitoshi Hashimoto; Kazuhiro Takuma; Toshio Matsuda
Journal:  Int J Neuropsychopharmacol       Date:  2017-05-01       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.